Systematic Review and Meta-analysis of Preclinical Studies
Enhancing Translational Research with Rigorous Evidence Synthesis
Preclinical studies form the foundation of translational medicine, guiding clinical trial design, drug development, and regulatory decision-making. However, the variability in experimental design, sample sizes, and outcome measures across preclinical research can introduce bias and limit reproducibility. Systematic reviews (SR) and meta-analyses (MA) of preclinical studies provide a structured and quantitative approach to aggregating preclinical evidence, ensuring data reliability, reducing bias, and informing future research.
At Clievi, we specialize in systematic review and meta-analysis of preclinical studies using advanced methodologies such as PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses), SYRCLE (Systematic Review Center for Laboratory Animal Experimentation), CAMARADES (Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies), and Cochrane methodologies.
Our comprehensive preclinical evidence synthesis services support pharmaceutical companies, biotech firms, research institutions, and regulatory agencies by identifying high-quality preclinical data, evaluating study validity, and performing robust statistical meta-analyses to generate translational insights.
Our Systematic Review & Meta-analysis Services for Preclinical Studies
1. Protocol Development & Registration
A well-defined systematic review protocol is essential to ensure reproducibility and transparency. We follow best practices in protocol development, including:
- Defining PICO (Population, Intervention, Comparison, Outcome) criteria for preclinical studies.
- Developing a structured review framework aligned with PRISMA and SYRCLE guidelines.
- Pre-registering the systematic review protocol on PROSPERO, SYRCLE, or Open Science Framework (OSF).
- Establishing inclusion/exclusion criteria to minimize selection bias.
2. Literature Search & Data Extraction
Our team conducts a comprehensive, systematic literature search across major biomedical databases, ensuring maximum coverage and minimal selection bias.
- Database Search: PubMed, Embase, Scopus, Web of Science, Cochrane Library, BIOSIS, and preprint archives (bioRxiv, medRxiv).
- Grey Literature & Regulatory Reports: Searching conference proceedings, unpublished studies, and regulatory documents (e.g., EMA/FDA preclinical submissions).
- Data Extraction & Standardization:
- Animal models and species used in preclinical studies.
- Intervention characteristics (dose, route of administration, treatment duration).
- Outcome measures (efficacy, toxicity, pharmacokinetics, biomarkers).
- Risk of bias indicators (randomization, blinding, allocation concealment).
3. Risk of Bias & Quality Assessment
To ensure data reliability and reproducibility, we conduct a rigorous quality assessment using validated tools:
- SYRCLE’s Risk of Bias Tool for assessing methodological bias in animal studies.
- CAMARADES Checklist for evaluating study quality, sample size calculation, and randomization methods.
- GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) framework for assessing the strength of preclinical evidence.
- Publication Bias Analysis: Funnel plot analysis, Egger’s regression test, and trim-and-fill methods.
4. Statistical Meta-analysis & Data Synthesis
Our biostatistics team employs advanced statistical methods to perform meta-analysis of preclinical data, quantifying treatment effects and variability.
- Effect Size Estimation: Calculating standardized mean differences (SMD), odds ratios (OR), and hazard ratios (HR).
- Random-effects & Fixed-effects Models: Selecting the appropriate statistical model based on heterogeneity assessment.
- Heterogeneity Analysis: Cochran’s Q test, I² statistic, and meta-regression analysis to explore variability.
- Subgroup & Sensitivity Analyses: Identifying potential confounders such as species differences, dose variations, and study design factors.
- Bayesian Meta-analysis: Applying Bayesian hierarchical models for more robust effect size estimation in preclinical research.
- Network Meta-analysis (NMA): Comparing multiple interventions simultaneously to establish relative efficacy rankings.
5. Data Visualization & Reporting
We present meta-analysis results using high-quality data visualization techniques:
- Forest Plots: Summarizing treatment effects with confidence intervals.
- Funnel Plots: Detecting publication bias and small-study effects.
- Cumulative Meta-analysis: Evaluating how evidence evolves over time.
- Heatmaps & Bubble Plots: Visualizing complex multi-variable relationships in preclinical studies.
Our final systematic review and meta-analysis reports are structured per PRISMA guidelines and include:
- Structured Abstract & Introduction
- Methods & Search Strategy Documentation
- Data Synthesis & Statistical Analysis
- Comprehensive Discussion & Implications for Clinical Translation
- Supplementary Material (Raw Data, PRISMA Flow Diagrams, Risk of Bias Tables)
Applications of Preclinical Systematic Review & Meta-analysis
- Drug Discovery & Development: Identifying promising preclinical candidates with strong evidence of efficacy.
- Translational Medicine: Enhancing the predictability of animal-to-human translation for clinical trial design.
- Regulatory Submissions: Supporting FDA, EMA, and MHRA regulatory applications with robust preclinical evidence synthesis.
- Biomedical Research Optimization: Reducing research redundancy and guiding future experimental designs.
- Precision Medicine & Biomarker Validation: Identifying potential biomarkers and mechanistic pathways for personalized medicine.
Why Choose Clievi for Preclinical Systematic Review & Meta-analysis?
- Expertise in Preclinical Research: Our team comprises biostatisticians, epidemiologists, pharmacologists, and systematic review specialists with deep domain expertise.
- Advanced Statistical & AI-Driven Meta-analysis: Utilizing machine learning and AI tools for data extraction, bias detection, and automated literature screening.
- Regulatory Compliance & Transparency: Our systematic reviews adhere to SYRCLE, CAMARADES, PRISMA, and Cochrane guidelines, ensuring regulatory acceptance.
- Comprehensive Data Interpretation: We go beyond data aggregation, providing actionable insights for clinical translation and regulatory decision-making.
- Customizable Reports & Manuscript Writing: We offer publication-ready systematic reviews for peer-reviewed journals and regulatory agencies.
Get Started with Clievi’s Systematic Review & Meta-analysis Services
Improve preclinical research reliability, reproducibility, and translational impact with Clievi’s expert systematic review and meta-analysis services. Contact us today to discuss your evidence synthesis needs.
Email:
Website: www.clievi.com